MedTrace Logo

Early Indicators of Chronic Rejection in Lung Transplant

NCT00449332 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2016-09-20

No results posted yet for this study

Summary

The purpose of this research is to discover the different patterns of cytokine production in patients who may develop Bronchiolitis Obliterans Syndrome-0p (BOS-0p) which means ongoing rejection. This is an early indicator of chronic rejection in lung transplant recipients. These cytokines can be detected in the bronchoalveolar (lung) and tissue samples of lung transplant recipients.

Conditions

  • Chronic Rejection in Lung Transplant
  • Cytokine Production in Bos Post Lung Transplant

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Principal Investigators

  • Sangeeta M Bhorade, MD · University of Chicago

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00449332 on ClinicalTrials.gov